Brief: Active Biotech Reports Positive Top-Line Results From LION Study
05/05/2025 12:03
May 5 (Reuters) - Active Biotech AB publ ACTI.ST: ACTIVE BIOTECH REPORTS POSITIVE TOP-LINE RESULTS FROM THE LION STUDY ON OCULAR ABSORPTION AND DISTRIBUTION OF LAQUINIMOD IN THE EYE LAQUINIMOD EYE DROP TREATMENT WAS SAFE AND TOLERABLE DURING 14 DAYS' ADMINISTRATION ACNO DOSE-LIMITING TOXICITIES WERE REPORTED IN ANY OF SUBJECTS Source text: ID:nMFN2WfCRP Further company coverage: ACTI.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))